CDY Chart, page-253

You say you have been holding for years but are now considering selling, just when revenue drivers such as évolis and CxBladder seem to get off the ground. We will also see the European market (and potentially the Chinese market) being approached with évolis at some point in the future. With sales going up, why would you consider selling now, just when there seems to be a chance to reach cash flow positive? This is a genuine question, out of curiosity.

Personally, I believe that the product becoming available worldwide will bring new investors on Cellmid's track. And with the weak Australian Dollar and the strong Euro/US Dollar, it seems to be a great time for European investors to buy Australian shares.

The only thing we need is sales showing a solid follow up and a good valuation from a research firm, in my view.